Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C33H43N5O5 |
| Molecular Weight | 589.725 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 6 / 6 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)C[C@@H]1N2C(=O)[C@](NC(=O)[C@H]3CN(C)[C@@H]4CC5=C(C)NC6=C5C(=CC=C6)C4=C3)(O[C@@]2(O)[C@@H]7CCCN7C1=O)C(C)C
InChI
InChIKey=AFFLEALSHYGOOD-NOURLPFCSA-N
InChI=1S/C33H43N5O5/c1-17(2)13-26-30(40)37-12-8-11-27(37)33(42)38(26)31(41)32(43-33,18(3)4)35-29(39)20-14-23-21-9-7-10-24-28(21)22(19(5)34-24)15-25(23)36(6)16-20/h7,9-10,14,17-18,20,25-27,34,42H,8,11-13,15-16H2,1-6H3,(H,35,39)/t20-,25-,26+,27+,32-,33+/m1/s1
| Molecular Formula | C33H43N5O5 |
| Molecular Weight | 589.725 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 6 / 6 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Mergocriptine (2-methyl-a-ergocryptine or CBM36-733) is a synthetic long-acting ergot derivative. It exerts agonistic action at dopamine receptors. Mergocryptine may induce the suppression of striatal dopamine turnover by reducing dopamine release via the stimulation of presynaptic dopaminergic autoreceptors. In animal experiments, it may affect cerebral hemodynamics. Mergocriptine has a protective effect on the brain against ischemia.
CNS Activity
Sources: https://www.ncbi.nlm.nih.gov/pubmed/2077182
Curator's Comment: Mergocriptine is CNS active in animals. No human data available.
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 19:26:33 GMT 2025
by
admin
on
Mon Mar 31 19:26:33 GMT 2025
|
| Record UNII |
VXD47YRH4Q
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
54803
Created by
admin on Mon Mar 31 19:26:33 GMT 2025 , Edited by admin on Mon Mar 31 19:26:33 GMT 2025
|
PRIMARY | |||
|
DTXSID501002339
Created by
admin on Mon Mar 31 19:26:33 GMT 2025 , Edited by admin on Mon Mar 31 19:26:33 GMT 2025
|
PRIMARY | |||
|
SUB08775MIG
Created by
admin on Mon Mar 31 19:26:33 GMT 2025 , Edited by admin on Mon Mar 31 19:26:33 GMT 2025
|
PRIMARY | |||
|
100000081711
Created by
admin on Mon Mar 31 19:26:33 GMT 2025 , Edited by admin on Mon Mar 31 19:26:33 GMT 2025
|
PRIMARY | |||
|
VXD47YRH4Q
Created by
admin on Mon Mar 31 19:26:33 GMT 2025 , Edited by admin on Mon Mar 31 19:26:33 GMT 2025
|
PRIMARY | |||
|
CHEMBL2105887
Created by
admin on Mon Mar 31 19:26:33 GMT 2025 , Edited by admin on Mon Mar 31 19:26:33 GMT 2025
|
PRIMARY | |||
|
C170163
Created by
admin on Mon Mar 31 19:26:33 GMT 2025 , Edited by admin on Mon Mar 31 19:26:33 GMT 2025
|
PRIMARY | |||
|
81968-16-3
Created by
admin on Mon Mar 31 19:26:33 GMT 2025 , Edited by admin on Mon Mar 31 19:26:33 GMT 2025
|
PRIMARY | |||
|
5762
Created by
admin on Mon Mar 31 19:26:33 GMT 2025 , Edited by admin on Mon Mar 31 19:26:33 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |